|
| Exchange Disseminated Time 01/08/2016 14:31:36 | Jagsonpal Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 12, 2016, to consider, approve and take on record the Un-audited Financial Results (provisional) of the Company for the quarter ended June 30, 2016.
Pursuant to the Code of Conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will remain closed for dealing in the securities of the Company for all the persons defined under the said Regulations including Director/Officer and Employees of the Company from August 05, 2016 till 48hrs from the date of declaration of the Un-audited Financial Results for the Quarter June 30, 2016. |
|
|